Search results
PTC Therapeutics Stock Tumbles: Company Stops Preclinical Gene Therapy Programs After Failed...
Benzinga via Yahoo Finance· 1 year agoPTC Therapeutics Inc (NASDAQ: PTCT) reported topline results from the MOVE-FA trial of vatiquinone...
FDA lifts hold on PTC Huntington’s disease trial
BioPharma Dive via Yahoo Finance· 1 day agoDive Brief: PTC Therapeutics said Thursday it can resume a Phase 2 trial of its Huntington’s disease drug in the U.S., following the Food and Drug...
PTC Therapeutics (PTCT) Up on Positive Regulatory Updates
Zacks via Yahoo Finance· 3 months agoPTC Therapeutics (PTCT) submits BLA for gene therapy Upstaza to the FDA and announces plans to...
PTC Therapeutics' (PTCT) Rare Disease Drug Fails in Study
Zacks via Yahoo Finance· 1 year agoPTC Therapeutics' (PTCT) vatiquinone did not achieve its primary endpoint in a late-stage study in...
PTC Therapeutics' Barrage Of Bad News Is Good News For Rival Reata Pharmaceuticals — Here's Why
Investor's Business Daily· 1 year agoPTC stock plummeted Wednesday and gave its closest rival a boost after the company's treatment for a...
PTC Therapeutics Stock Soars As Its Biggest Drug 'Lives To Fight Another Day'
Investor's Business Daily· 1 month agoPTC stock hit a nine-month high Monday after the European Commission decided against pulling its...
Promising gene therapy delivers treatment directly to brain
Associated Press via Yahoo News· 1 year agoWhen Rylae-Ann Poulin was a year old, she didn’t crawl or babble like other kids her age. A rare...
PTC Therapeutics (PTCT) to Cut 25% Jobs by January 2024
Zacks via Yahoo Finance· 9 months agoPTC Therapeutics (PTCT) will reduce its workforce in accordance with its strategic prioritization...
PTC Therapeutics, Inc. (NASDAQ:PTCT) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 2 months agoPTC Therapeutics, Inc. (NASDAQ:PTCT) Q1 2024 Earnings Call Transcript April 25, 2024 PTC...
A Comprehensive Look at Sarepta's Growth and Innovation
GuruFocus.com via Yahoo Finance· 3 months agoSarepta Therapeutics, Inc. (NASDAQ:SRPT) is an American pharmaceutical company leading the global...